Impact of abdominal fat distribution on sepsis: A comparison with traditional anthropometric indices in the UK Biobank study.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Yang Yang, Zhenyu Peng, Wenbin Nan, Hongliang Zhang, Zhenhua Xing
{"title":"Impact of abdominal fat distribution on sepsis: A comparison with traditional anthropometric indices in the UK Biobank study.","authors":"Yang Yang, Zhenyu Peng, Wenbin Nan, Hongliang Zhang, Zhenhua Xing","doi":"10.1111/dom.16407","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study aims to examine the dose-response relationship between visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and sepsis and sepsis-related mortality. Additionally, we seek to determine whether VAT or ASAT offers better prognostic value for above outcomes compared to traditional measures such as waist circumference (WC) and body mass index (BMI), using data from the UK Biobank.</p><p><strong>Materials and methods: </strong>In this secondary analysis of the UK Biobank, 25,083 participants with available abdominal MRI data were included. Cox proportional hazards regression was used to examine the association between VAT and ASAT, both as tertiles and continuous variables, and the incidence of sepsis as well as sepsis-related mortality.</p><p><strong>Results: </strong>Over a median follow-up of 14.1 years (interquartile range: 13.4-14.9 years), 305 cases of incident sepsis (0.86 per 1000 person-years) and 90 sepsis-related deaths (0.25 per 1000 person-years) were identified. Both VAT and ASAT showed a linear relationship with sepsis risk, with hazard ratios (HR) of 1.29 (95% CI: 1.12-1.47) for VAT and 1.22 (95% CI: 1.07-1.40) for ASAT per standard deviation increase. After further adjusting for BMI or WC, the association with ASAT was eliminated, while VAT remained significant. Only VAT was positively associated with sepsis-related mortality, although this association was nullified after adjusting for BMI or WC. VAT was a more important predictor of sepsis risk than BMI or WC, and its inclusion improved the predictive model already adjusted for BMI or WC. In contrast, ASAT did not provide any additional predictive value for either sepsis risk or sepsis-related mortality compared to BMI and WC.</p><p><strong>Conclusions: </strong>VAT is independently associated with sepsis risk and improves its prediction beyond traditional measures like BMI and WC. However, VAT does not enhance the prediction of sepsis-related mortality, with BMI and WC performing better in this context.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.16407","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study aims to examine the dose-response relationship between visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and sepsis and sepsis-related mortality. Additionally, we seek to determine whether VAT or ASAT offers better prognostic value for above outcomes compared to traditional measures such as waist circumference (WC) and body mass index (BMI), using data from the UK Biobank.

Materials and methods: In this secondary analysis of the UK Biobank, 25,083 participants with available abdominal MRI data were included. Cox proportional hazards regression was used to examine the association between VAT and ASAT, both as tertiles and continuous variables, and the incidence of sepsis as well as sepsis-related mortality.

Results: Over a median follow-up of 14.1 years (interquartile range: 13.4-14.9 years), 305 cases of incident sepsis (0.86 per 1000 person-years) and 90 sepsis-related deaths (0.25 per 1000 person-years) were identified. Both VAT and ASAT showed a linear relationship with sepsis risk, with hazard ratios (HR) of 1.29 (95% CI: 1.12-1.47) for VAT and 1.22 (95% CI: 1.07-1.40) for ASAT per standard deviation increase. After further adjusting for BMI or WC, the association with ASAT was eliminated, while VAT remained significant. Only VAT was positively associated with sepsis-related mortality, although this association was nullified after adjusting for BMI or WC. VAT was a more important predictor of sepsis risk than BMI or WC, and its inclusion improved the predictive model already adjusted for BMI or WC. In contrast, ASAT did not provide any additional predictive value for either sepsis risk or sepsis-related mortality compared to BMI and WC.

Conclusions: VAT is independently associated with sepsis risk and improves its prediction beyond traditional measures like BMI and WC. However, VAT does not enhance the prediction of sepsis-related mortality, with BMI and WC performing better in this context.

腹部脂肪分布对脓毒症的影响:与英国生物银行研究中传统人体测量指标的比较。
目的:本研究旨在探讨内脏脂肪组织(VAT)、腹部皮下脂肪组织(ASAT)与败血症及败血症相关死亡率之间的剂量-反应关系。此外,我们试图确定VAT或ASAT是否比传统的测量方法(如腰围(WC)和体重指数(BMI))对上述结果有更好的预测价值,使用的数据来自UK Biobank。材料和方法:在英国生物银行的二次分析中,纳入了25,083名具有可用腹部MRI数据的参与者。采用Cox比例风险回归来检验VAT和ASAT之间的关系,无论是作为连续变量还是连续变量,以及败血症发生率和败血症相关死亡率。结果:在14.1年的中位随访中(四分位数范围:13.4-14.9年),发现305例败血症(0.86 / 1000人年)和90例败血症相关死亡(0.25 / 1000人年)。VAT和ASAT均与脓毒症风险呈线性关系,每个标准差增加的VAT风险比(HR)为1.29 (95% CI: 1.12-1.47), ASAT风险比(HR)为1.22 (95% CI: 1.07-1.40)。在进一步调整BMI或WC后,与ASAT的关联被消除,而VAT仍然显著。只有VAT与败血症相关的死亡率呈正相关,尽管这种关联在调整BMI或WC后无效。VAT是比BMI或WC更重要的脓毒症风险预测因子,其纳入改进了已经调整过BMI或WC的预测模型。相比之下,与BMI和WC相比,ASAT对败血症风险或败血症相关死亡率没有提供任何额外的预测价值。结论:VAT与败血症风险独立相关,其预测能力优于BMI和WC等传统指标。然而,VAT并不能提高对败血症相关死亡率的预测,BMI和WC在这方面表现更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信